Most human T-lymphotropic virus type 1 (HTLV-1)-infected patients remain asymptomatic throughout life. The factors associated with HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) development have not been fully elucidated; immunological and genetic factors may be involved. The association of 14 bp INS/DEL HLA-G polymorphism with HTLV-1 infection susceptibility has been reported previously. Here, other polymorphic sites at the HLA-G 3¢-UTR (14-bp D/I, +3003C/T, +3010C/G, +3027A/C, +3035C/T, +3142C/G, +3187A/G and +3196C/G) were evaluated in 37 HTLV-1-infected individuals exhibiting HAM/TSP, 45 HTLV-1 asymptomatic carriers (HAC) and 153 uninfected individuals, followed up at University Hospital of the Faculty of Medicine of Ribeirão Preto, University of São Paulo, Brazil. It was observed that: (i) 14bpDI genotype is a risk factor for HTLV-1 infection, while the 14bpDD and +3142CC genotypes were associated with protection against infection; (ii) the +3142C allele and the +3003CT and +3142CC genotypes were associated with susceptibility, while 14bpII and +3003TT genotypes were associated with protection against HAM/TSP development; and (iii) the 14bpII, +3010CC, +3142GG and +3187AA genotypes were associated with lower HTLV-1 proviral load compared to respective counterpart genotypes. Findings that HLA-G has a well-recognized immunomodulatory role and that the genetic variability at HLA-G 3¢-UTR may post-transcriptionally modify HLA-G production indicate a differential genetic susceptibility to: (i) the development of HTLV-1 infection, (ii) the magnitude of HTLV-1 proviral load and (iii) HAM/TSP development.
individuals (95-98 %) remain asymptomatic throughout their life and, to date, the mechanisms that trigger the symptoms are not fully understood (Verdonck et al., 2007) . Evidence indicates that the progression to HTLV-1-related diseases is multifactorial and is not totally dependent on viral factors (Bangham, 2003) . Immunological factors and the host genetic background have also been related to the development of HTLV-1-associated disorders (Sabouri et al., 2005; Goncalves et al., 2008; Costa et al., 2009; Kashima et al., 2009; Rocha-Júnior et al., 2012) . For instance, HLA alleles have been associated with HAM/TSP development (Treviño et al., 2013) .
HLA-G is a non-classical MHC class I molecule primarily expressed in immune-privileged sites. This molecule exerts important tolerogenic functions, by inhibiting the immune response under physiological conditions, such as effective embryo implantation and in the establishment of maternalfoetal symbiosis during human pregnancy . Under pathological conditions, such as malignant transformation, allogeneic transplantation, inflammatory conditions, autoimmune diseases and viral infections, the HLA-G molecule can also be neo-expressed, producing favourable or unfavourable effects according to the underlying disorder (Carosella, 2011) . This characteristic had led to investigation of the role of HLA-G in several disorders, aiming the possible use of the recombinant molecule or of the specific antibody on the prevention, diagnosis and treatment of disorders depending on the underlying immunological mechanisms (Bortolotti et al., 2014a) .
One of the major mechanisms that viruses use to evade immune response is the inhibition of classical HLA class I molecules and the induction of non-classical HLA-G expression (Bortolotti et al., 2014a) , preventing the cytotoxic activity of T CD8 and NK cells (Tripathi & Agrawal, 2007; Rizzo et al., 2014) . Although the mechanisms of virus modulation of HLA-G expression have not been elucidated, several mechanisms that affect transcriptional and post-transcriptional HLA-G expression have been reported (Moreau et al., 2009; Donadi et al., 2011; Rizzo et al., 2014) . Particularly at the 3¢-UTR, three polymorphisms have been reported to post-transcriptionally regulate HLA-G expression: (i) the 14 bp deletion/insertion (14-bp D/I), which influences alternative splicing and mRNA stability (Rousseau et al., 2003) ; (ii) the single-nucleotide polymorphism (SNP) at the +3142 position (+3142G/C), in which the +3142G allele is target for the microRNAs 148a, 148b and 152, leading to mRNA degradation (Tan et al., 2007) ; and (iii) the SNP at the +3187 position (+3187A/G), which is associated with the stability and degradation of mRNA due to its close proximity to AUrich elements (Yie et al., 2008) . To date, no correlation with HLA-G expression has been observed for the other HLA-G polymorphisms (+3003C/T, +3010C/G, +3027A/C, +3035C/T and +3196C/G).
In a previous study, it was reported that the 14-bp D/I polymorphism at the HLA-G 3¢-UTR was associated with susceptibility to HTLV-1 infection: the frequency of the 14bpDI genotype was higher in HTLV-1-infected patients compared to uninfected individuals (Haddad et al., 2011) . In the present study, we analysed other polymorphic sites at the HLA-G 3¢-UTR, including the 14-bp D/I (GenBank ID rs1704), +3003C/ T (rs1707), +3010C/G (rs1710), +3027A/C (rs17179101), +3035C/T (rs17179108), +3142C/G (rs1063320), +3187A/G (rs9380142) and +3196C/G (rs1610696), in HTLV-1-infected individuals exhibiting or not exhibiting clinical symptoms of HAM/TSP, as well as in uninfected individuals. In addition, the HTLV-1 proviral load of the infected individuals was associated with each one of these polymorphisms.
RESULTS
Eighty-two HTLV-1-infected individuals (31 men and 51 women), aged 15-73 years (mean=45.03±13.91 years), were genotyped for eight polymorphic sites of the 3¢-UTR of HLA-G (14-bp D/I, +3003C/T, +3010C/G, +3027A/C, +3035C/T, +3142C/G, +3187A/G and +3196C/G). The mean age and the mean proviral load of the HAM/TSP group were significantly higher when compared to the HTLV-1 asymptomatic carriers (HAC) group (P<0.0001 and P=0.0021, respectively) ( Table 1) . The allele and genotype frequencies of all polymorphisms and HardyWeinberg equilibrium (HWE) were determined in HTLV-1-infected patients (HAC and HAM/TSP) and healthy control groups. Adherences of genotypic proportions were found in all groups (data not shown).
Comparison among HAC vs HAM/TSP, HAC vs healthy control, HAM/TSP vs healthy control and HTLV-1-infected individuals vs healthy control revealed no differences for +3027A/ C, +3035C/T, +3187A/G and +3196C/G polymorphisms. On the other hand, statistical differences were observed for allelic and/or genotypic frequencies of 14-bp D/I, +3003C/T, +3010C/G and +3142C/G polymorphisms after comparison among groups. It was observed that the frequency of the 14bpDD genotype was lower in HTLV-1-infected individuals than in the healthy control group [P=0.0438, odds ratio (OR) 0.5336 and 95 % confidence interval (CI) 0.2950-0.9653]. In contrast, the frequency of the 14bpDI genotype was higher in HTLV-1-infected individuals compared to the healthy control group (P=0.0196, OR 1.963 and 95 % CI 1. 139-3.389 Table 2 .
To determine whether the polymorphic sites at the HLA-G 3¢-UTR were segregating independently, linkage disequilibrias (LDs) among them were evaluated. Strong LDs (P<0.001 for each comparison) were observed for 21 of 28 pairs of polymorphic sites. The exceptions were those between +3003 and +3027, +3003 and +3035, +3003 and +3187, +3003 and +3196, +3010 and +3027, +3027 and +3142, +3027 and +3196 and +3035 and +3027 SNPs. Considering all samples (HTLV-1-infected patients and healthy controls), the observed LD allowed the application of computational haplotype inference procedures (Table 3 ). The presence of 13 3¢-UTR haplotypes was observed, as shown in Table 4 . The frequency of UTR-4 (DCGCCCAC) was lower in the HAC group compared to the healthy control group (P=0.0407 OR 0.3802 and 95 % CI 0.1455-0.9932). On the other hand, the frequency of UTR-8 (DTGCCGGC) was higher in the HAC group compared to the healthy control group (P=0.0114, OR 24.52 and 95 % CI 1.254-479.6). UTR-8 and UTR-9 (ITCCCGAC) were more frequent in HTLV-1-infected patients than the healthy control group (P=0.0420 OR 13.28 and 95 % CI 0.6815-0.259 for both comparisons) ( Table 4) . †Comparisons between HTLV-1-infected individuals and healthy control, performed by two-sided FET or by an exact test that employs the MET to obtain an unbiased estimate of the exact P-value for a given RÂC contingency table and means by two-sided t-test, two-sided MW.
‡Comparisons performed by two-sided FET revealed significant differences in gender between HTLV-1-infected individuals and healthy control groups (P<0.001, Odds ratio=0.2376 and 95 % confidence interval=02821-0.5821). §MW comparison revealed significant differences in age between HAC and HAM/TSP patients (P<0.0001). ||MW comparison revealed significant differences in age between HTLV-1-infected individuals and healthy controls, (P<0.0001). ¶ MW comparison revealed significant differences in proviral load between HAC and HAM/TSP patients (P=0.0021). Lastly, we compared proviral load among the three different genotypes for each polymorphism studied. Table 5 and Fig. 1 show that the +3010CC genotype is related to lower levels of HTLV-1 proviral load compared to +3010CG (P=0.0034) and +3010GG (P=0.0145) genotypes (Fig. 1c) . Additionally, the HTLV-1 proviral load was also lower in the +3142GG genotype than +3142GC (P=0.0030) and +3142CC (P=0.0094) (Fig. 1f) . The +3187AA genotype also presented lower levels of HTLV-1 proviral load compared to +3187AG (P=0.0093) and +3187GG genotypes (no significance) (Fig. 1g) . Regarding the other HLA-G 3¢-UTR genotypes, no significant differences in proviral load were observed (Table 5 and Fig. 1) .
DISCUSSION
It has been demonstrated that several genetic polymorphisms can exert influence in human clinical virology, including the establishment of infection, disease progression and treatment outcome (Soriano et al., 2012; Aceti et al., 2015; Wang et al., 2016) . Specifically, HLA-G polymorphisms have been associated with susceptibility to viral infections or viral infection outcomes. For instance, the 14-bpD/I polymorphism has been related to cytomegalovirus (CMV), papillomavirus (HPV) and retrovirus infections (such as HIV-1) (Cordero et al., 2009; Fabris et al., 2009; Zheng et al., 2009; Jin et al., 2012; Bortolotti et al., 2014b; Segat et al., 2014) . The +3142G/ C polymorphism has been studied in HPV, HCV and HBV (Cordero et al., 2009; Jiang et al., 2011; Xu et al., 2014; Yang et al., 2014) .
In a previous study, it was observed that the 14bpDI genotype presented higher frequency in HTLV-1-infected patients (HAC+HAM/TSP+ATLL) compared to uninfected individuals (Haddad et al., 2011) . Since other polymorphic sites at this gene segment may post-transcriptionally influence HLA-G expression, the role of these variation sites in HTLV-1 infection, HAM/TSP development and proviral load levels was evaluated. Besides confirming the increased frequency of the 14bpDI genotype in HTLV-1-infected patients (HAC+HAM/ TSP) compared to uninfected individuals, the frequency of the +3142CC genotype was higher in the uninfected group compared to HTLV-1-infected patients. In addition, the frequency of UTR-8 and UTR-9 was higher in HTLV-1-infected patients compared to uninfected individuals. Taken together, these results indicate that the 14bpDI genotype is a risk factor for HTLV-1 infection, while the 14bpDD and +3142CC genotypes possess protective effects against the infection. Despite the differences of frequencies of UTR-8 and UTR-9 between infected and uninfected individuals, it is not correct to conclude that these haplotypes are associated with susceptibility to HTLV-1 infection, since these haplotypes are absent in uninfected individuals and present at very low frequencies in HTLV-1-infected individuals group compared to the other haplotypes.
The influence of HLA-G polymorphisms in HAM/TSP development in HTLV-1-infected individuals was also evaluated, comparing the frequencies of all HLA-G 3¢-UTR polymorphisms between HAC and HAM/TSP groups. The frequency of the +3003CT genotype was significantly higher in the HAM/TSP group, while the frequency of the +3003TT genotype was significantly higher in the HAC group. These results indicate that the +3003CT genotype is associated with HAM/TSP development while the +3003TT genotype is related to protection against this HTLV-1-related disease. To our knowledge, this is the first study to associate +3003C/T polymorphism with an outcome of viral infection. However, more studies about the participation of this polymorphism in the regulation of HLA-G molecule expression are essential to better understand the role of this variation site on the development of HAM/TSP. In addition, the frequency of the +3142C allele was over-represented in the HAM/TSP compared to the HAC group. Despite the absence of significance, the HAM/TSP group presented a higher frequency of the +3142CC genotype than the HAC group (approximately four fold). Likewise, the frequency of the 14bpII genotype is approximately two fold higher in asymptomatic individuals (HAC) compared to HAM/TSP patients. The +3142C allele and +3142CC genotype may thus favour HAM/TSP development, while the 14bpII genotype may exert protector effects against the development of HAM/TSP.
Considering that: (i) the presence of the +3142C allele is associated with increased expression of HLA-G (Tan et al., 2007) ; (ii) the presence of 14 bp insertion exerts an opposite effect, decreasing HLA-G production (Hviid et al., 2003; Rousseau et al., 2003) ; (iii) the proviral load is associated with symptom development (Nagai et al., 1998) ; and (iv) our results indicated that some HLA-G polymorphisms may be related to HAM/TSP development, it is becomes interesting to associate proviral load with HLA-G 3¢-UTR polymorphisms. It was observed that individuals exhibiting the +3142GG and 14bpII genotypes (both associated with lower production of HLA-G) presented lower proviral load compared to the respective counterpart genotypes. These results reinforce that the +3142CC genotype may be related to HAM/TSP development, whereas 14bpII exerts a protective effect against HAM/TSP development. Therefore, the lower production of HLA-G may favour immune attack against infected cells, leading to a reduction of HTLV-1 proviral load and prevention of HAM/TSP. In agreement with this idea are the following findings: (i) the HTLV-1-infected MT-2 cell line expresses HLA-G, which possibly confers resistance against cell lysis by NK cells (Komatsu & Yoshida, 1999) ; (ii) HTLV-1 proviral load has a negative correlation *Comparisons of medians of HTLV-1 proviral load among the three genotype groups performed by KW followed by Dunn's multiple comparison post-test or between the two genotype groups performed by MW. Considered significant at P<0.05. †KW followed by Dunn's multiple comparison post-test revealed significant differences in +3010CC vs +3010CG (P=0.0034) comparison by MW, in +3010CC vs +3010GG (P=0.0145) comparison by MW and no significant differences in +3010CG vs +3010GG comparison by MW. ‡MW requires at least three values in each group. Genotype +3027AA (n=0) and genotype +3027AC (n=2). §KW followed by Dunn's multiple comparison post-test revealed significant differences in +3142CC vs +3142GG (P=0.0094) comparison by MW, in +3142CG vs +3142GG (P=0.0030) comparison by MW and no significant differences in +3142CC vs +3142GG comparison by MW. ||KW followed by Dunn's multiple comparison post-test revealed significant differences in +3187AA vs +3187AG (P=0.0093) comparisons by MW, and no significant differences in +3187AA vs +3187GG comparisons (MW was not performed for this comparison because only one patient presented with +3187GG genotype) and in +3187AG vs +3187GG comparison by MW.
with the lysis rate of infected cells (Asquith et al., 2005) ; and (iii) a positive correlation has been observed between HTLV-1 proviral load and the development of HAM/TSP (Nagai et al., 1998; Asquith & Bangham, 2007) .
Here, we also observed that proviral load is significantly higher in HAM/TSP compared to the HAC group, supporting the pre-existing idea that proviral load has an important role in HAM/TSP development and may be useful as a predictive marker of disease (Manns et al., 1999; Yamano et al., 2002) . Still, our results point to the influence of +3142G/C and 14-bpD/I HLA-G polymorphisms on the HTLV-1 proviral load levels. Taken together, these data support the idea that the levels of HLA-G expression may be directly related to the protective effect of HTLV-1-infected cells, resulting in the development of HAM/TSP in patients with higher proviral load. Likewise, the +3010C/G and +3187A/G polymorphisms also appear to influence the HTLV-1 proviral load. The +3010CC genotype is related to lower levels of HTLV-1 proviral load compared to the HLA-G +3010CG and GG genotypes. The +3187AA genotype also presented lower levels of HTLV-1 proviral load compared to +3187AG and GG (although this study presented only one patient with +3187GG genotype and proviral load available). A recent study demonstrated that the +3010CC and +3187AA genotypes are associated with lower expression of soluble HLA-G (Martelli- Palomino et al., 2013) . The +3187A allele is associated with increased degradation of HLA-G mRNA and, consequently, lower expression of HLA-G (Yie et al., 2008) . Based on these studies, it is possible to hypothesize that the +3010CC and +3187AA genotypes may lead to lower expression of HLA-G which, in turn, allows the immune system cells to attack HTLV-1-infected cells, and thus, the proviral load is maintained at low levels. Although these polymorphic sites were not associated with HAM/TSP development in this study, it is important to note that the proviral load levels of HAM/ TSP patients and asymptomatic individuals are widely variable and overlapping. Thus, we should also take into account the possibility that a high proviral load alone is not capable of causing the symptoms (Asquith & Bangham, 2007) .
In conclusion, the present study points to the involvement of HLA-G 3¢-UTR polymorphisms in HTLV-1 susceptibility, proviral load levels and HAM/TSP development; however, the detailed function of the HLA-G molecule in HTLV-1 infection and in the outcome of the disease remains to be further explored. Future studies encompassing higher number of individuals of other ethnic backgrounds, as well as functional studies involving HTLV-1 and the HLA-G molecule, can help to solve these questions.
METHODS
Patients and controls. A total of 82 HTLV-1-infected individuals (followed up at University Hospital of the Faculty of Medicine of Ribeirão Preto, University of São Paulo, Brazil -HCFMRP-USP) and 153 unrelated healthy bone marrow donors (registered at the Transplant Unit of HCFMRP-USP) were included in the study. Thirty-seven HTLV-1-infected individuals were symptomatic (HAM/TSP) and 45 exhibited no clinical symptoms (HAC). The study was approved by the Local Institutional Ethics Committees (protocol numbers 7639/2005 and 7581/2007) and written informed consent was obtained from both patients and healthy volunteers. ATLL patients were not evaluated in this study.
Assignment of HLA-G 3¢-UTR polymorphisms. All specimens included in this study were screened for HTLV-1/2 infection by ELISA, and the results were confirmed by PCR (tax and LTR regions). Neither HTLV-2-infected nor HTLV-1/2-co-infected individuals were included in the analyses.
DNA samples of HTLV-1-infected patients and healthy control groups were extracted from the PBMCs using the Super QuikGene DNA Isolation Kit (Promega) according to the manufacturer's instructions. The HLA-G 3¢-UTR polymorphic sites were evaluated as previously described (Castelli et al., 2010) . In brief, the 3¢-UTR of the HLA-G gene of each individual was amplified by PCR [primers HLAG8F: 5¢-TG TGAAACAGCTGCCCTGTGT-3¢ (Bermingham et al., 2000) and HLAG8R: 5¢-GTCTTCCATTTATTTTGTCTCT-3¢], and the amplified products were checked by electrophoresis over 7 % polyacrylamide gel stained with silver. PCR products were directly sequenced using a 3500 XL Genetic Analyzer (Applied Biosystems) and the BigDye 3.1 Sequencing Kit (Applied Biosystems), using the reverse HLAG8R primer. Then, all the single-nucleotide polymorphisms (SNPs) were individually annotated.
Determination of the proviral load. The proviral load was determined according to conditions previously reported (Haddad et al., 2011) . Briefly, quantitative real-time PCR was performed for each sample using HTLV-1 tax as target and human b-actin (ACTB) as endogenous control. All reactions were performed in duplicate and in separate wells using the ABI Prism 7500 system and SYBR green I dye (Applied Biosystems). Proviral load was calculated using the following formula: average of tax/average of ACTBÂ2Â10 5 , and the values obtained (copy numberÂ10 5 cells) were transformed using the log 10 scale.
Statistical analyses. Comparisons of clinical and demographic data between patients (HAC and HAM/TSP) and healthy volunteers were performed using GraphPad INSTAT 3.06 software. The Kruskal-Wallis test followed by Dunn's multiple comparisons post-test (non-parametric) was used for comparisons among groups. The Mann-Whitney test (non-parametric) was used for comparisons between groups. The Kolmogorov-Smirnov normality test was used for decisions relating to the application of parametric or non-parametric tests. The two-sided Fisher's exact test was used for comparison of absolute number of subjects for 2Â2 contingency tables. Larger contingency tables were evaluated by means of an exact test that uses the Metropolis algorithm to obtain an unbiased estimate of the exact P-value and its standard error using RÂC software (http://www.marksgeneticsoftware.net/rxc.htm).
The direct counting method was used to compute allelic and genotypic frequencies. The GENEPOP 3.4 software (Raymond & Rousset, 1995) [exact test of Guo & Thompson (1992) ] was used for testing the adherence of genotypic proportions to expectations under Hardy-Weinberg equilibrium. Significant association between each polymorphism detected at the 3¢-UTR of the HLA-G gene was evaluated by a likelihood-ratio test of LD (Excoffier & Slatkin, 1998) , using ARLEQUIN version 3.1 software (Excoffier et al., 2005) . Given the significant LD in the majority of comparisons, the PHASE method (Stephens et al., 2001 ) was used to infer 3¢-UTR haplotypes, as previously described (Castelli et al., 2010) . The expected heterozygosity values (hSk) and haplotype diversity, as well as their SD, were estimated using Arlequin (Excoffier et al., 2005) . Allele, haplotype and genotype frequencies were compared by the twosided Fisher's exact test, with the assistance of the GraphPad InStat software, which was also used to estimate OR and 95 % CI.
